Latest News

All the news from Anaphylaxis UK

Looking for Allergy Alerts?

Allergy Alerts

Latest News from Anaphylaxis UK

A Tribute to Jenson 30th April 2026

Today, we’re remembering Jenson Joseph. Losing him so young, aged just 25 on 30 April 2024, was the result of a rare anaphylactic reaction as he lay sleeping. Diagnosed with a peanut and almond allergy at the age of 21,
[…]

Read more
Why accessible colour matters to allergy safety in schools 28th April 2026

By Marie Difolco, author of ‘Supporting Colour Blindness in Education and Beyond‘ When people think about allergy safety in schools, they rightly think about training, Individual Healthcare Plans, clear labelling and access to adrenaline devices. What they do not usually
[…]

Read more
Nine years on: remembering Owen Carey 22nd April 2026

Today we remember Owen Carey – an 18-year-old young man who died after experiencing a fatal allergic reaction while celebrating his birthday on 22 April 2017 at a London restaurant with his family and girlfriend. Owen had multiple food allergies and made staff aware of them
[…]

Read more

News Type:

The Anaphylaxis Campaign and Covid-19 17th March 2020

We have been closely monitoring the developing COVID-19 outbreak and want to reassure you that we are making plans to ensure we can continue to operate as usual and provide our much-needed services and resources to anyone who needs them.

Read more
Statement regarding death of Nicholas Kelly 12th March 2020

We are saddened to learn of the tragic death of Nicholas Kelly, aged 16, due to a suspected allergic reaction, and would like to offer our deepest sympathies to his family at this difficult time. We have very little detail

Read more
MHRA issues important alert for Emerade 150/300/500mcg auto-injectors 4th March 2020

4th March 2020 The UK’s regulator of medicines (Medicines & Healthcare products Regulatory Agency [MHRA]) has received updated information from the company that makes Emerade pens about the defect previously reported by the MHRA. The defect means some pens may

Read more
Survey: Making allergy, skin disease and asthma care better for young people 28th February 2020

Developing new guidance for healthcare professionals looking after teenagers and young adults with allergies and/or asthma. It is important that young people learn how to self-manage their allergies and/or asthma. Adolescence can be a challenging time for them and their

Read more
Food Standards Agency Survey: Improving life for people with Food Hypersensitivity 21st February 2020

The Food Standards Agency (FSA) are inviting those affected or interested in food hypersensitivity to participate in an online survey and share their experiences. Around 2% of adults and 8% of children in the UK have a food hypersensitivity. This

Read more
Latest statement on availability of EpiPen® 0.3mg and 0.15mg Adrenaline Auto-Injectors 14th February 2020

The Anaphylaxis Campaign has received the following updated statement from Mylan regarding the availability of EpiPen. This includes information for patients, prescribers, pharmacists, hospitals and schools. Mylan’s manufacturing partner Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen®, has

Read more
Statement regarding the death of Sam Collings 13th February 2020

The Anaphylaxis Campaign is saddened to learn of the death of Sam Collings, aged 19,  who died at Bolton Hospital on the 4th August 2019. According to media reports, neither Sam or his family had suspected that Sam suffered from

Read more
First Oral Immunotherapy Drug ‘Palforzia’ gets FDA Approval 3rd February 2020

The Anaphylaxis Campaign is delighted to hear about the success of Aimmune Therapeutics, Inc. in the approval of their oral immunotherapy drug, Palforzia, by the US Food and Drug Administration (FDA). This is the first oral immunotherapy drug that has

Read more
Clinicians & Charities Call For Urgent Action to Keep Food Allergic Children Safe in School 29th January 2020

An editorial in the February edition of Clinical and Experimental Allergy (the official journal of the British Society of Allergy and Clinical Immunology) explores the current statutory guidance on the care of children with medical conditions in schools, and highlights

Read more